Cargando…

Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide‐induced hepatic steatosis in rats

Ethionamide (ETH), a second‐line drug for multidrug‐resistant tuberculosis, is known to cause hepatic steatosis in rats and humans. To investigate predictive biomarkers for ETH‐induced steatosis, we performed lipidomics analysis using plasma and liver samples collected from rats treated orally with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muta, Kyotaka, Saito, Kosuke, Kemmochi, Yusuke, Masuyama, Taku, Kobayashi, Akio, Saito, Yoshiro, Sugai, Shoichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546090/ https://www.ncbi.nlm.nih.gov/pubmed/35315511 http://dx.doi.org/10.1002/jat.4324

Ejemplares similares

Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human—Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans-
por: Goda, Keisuke, et al.
Publicado: (2017)

Ethionamide-induced gynecomastia
por: Dixit, Ramakant, et al.
Publicado: (2012)

Gynecomastia caused by ethionamide
por: Sharma, Parveen K., et al.
Publicado: (2012)

Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer
por: Ishikawa, Seiji, et al.
Publicado: (2012)

Decrease in Sphingomyelin (d18:1/16:0) in Stem Villi and Phosphatidylcholine (16:0/20:4) in Terminal Villi of Human Term Placentas with Pathohistological Maternal Malperfusion
por: Yamazaki, Kaori, et al.
Publicado: (2015)

Decreasing Phosphatidylcholine on the Surface of the Lipid Droplet Correlates with Altered Protein Binding and Steatosis
por: Listenberger, Laura, et al.
Publicado: (2018)

Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
por: Vilchèze, Catherine, et al.
Publicado: (2008)

EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
por: Ang, Michelle L. T., et al.
Publicado: (2017)

Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
por: Zhang, Hai-Nan, et al.
Publicado: (2017)

Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis
por: Ushtanit, Anastasia, et al.
Publicado: (2022)

Regression of Liver Steatosis Following Phosphatidylcholine Administration: A Review of Molecular and Metabolic Pathways Involved
por: Osipova, D., et al.
Publicado: (2022)

Revisiting the susceptibility testing of Mycobacterium tuberculosis to ethionamide in solid culture medium
por: Lakshmi, Rajagopalan, et al.
Publicado: (2015)

Application of Cerium (IV) as an Oxidimetric Agent for the Determination of Ethionamide in Pharmaceutical Formulations
por: Basavaiah, Kanakapura, et al.
Publicado: (2016)

Ethionamide‐induced acneiform drug eruption in a patient with multiresistant tuberculosis
por: Chen, Jessica, et al.
Publicado: (2022)

Fasting increases 18:2-containing phosphatidylcholines to complement the decrease in 22:6-containing phosphatidylcholines in mouse skeletal muscle
por: Senoo, Nanami, et al.
Publicado: (2021)

Increased phosphatidylcholine (16:0/16:0) in the folliculus lymphaticus of Warthin tumor
por: He, Qian, et al.
Publicado: (2014)

Dilemmas with ethionamide susceptibility testing of Mycobacterium tuberculosis: A microbiologist & physician's nightmare
por: Varma-Basil, Mandira, et al.
Publicado: (2015)

Graphene oxide-based electrochemical activation of ethionamide towards enhanced biological activity
por: Mulik, Balaji B., et al.
Publicado: (2019)

Selenium and Glutathione-Depleted Rats as a Sensitive Animal Model to Predict Drug-Induced Liver Injury in Humans
por: Goda, Keisuke, et al.
Publicado: (2019)

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
por: Maev, Igor V, et al.
Publicado: (2020)

Erratum to: Increased phosphatidylcholine (16:0/16:0) in the folliculus lymphaticus of Warthin tumor
por: He, Qian, et al.
Publicado: (2014)

Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds
por: Tatum, Natalie J., et al.
Publicado: (2019)

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2017)

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
por: Pillay, Samantha, et al.
Publicado: (2022)

Increased Susceptibility of Mycobacterium tuberculosis to Ethionamide by Expressing PPs-Induced Rv0560c
por: Seo, Hoonhee, et al.
Publicado: (2022)

Consistency of standard laboratory strain Mycobacterium tuberculosis H(37)Rv with ethionamide susceptibility testing
por: Lakshmi, R., et al.
Publicado: (2012)

Metabolism and Pharmacokinetics of the Anti-Tuberculosis Drug Ethionamide in a Flavin-Containing Monooxygenase Null Mouse
por: Palmer, Amy L., et al.
Publicado: (2012)

Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Lee, Na-Hee, et al.
Publicado: (2020)

The Value of the inhA Mutation Detection in Predicting Ethionamide Resistance Using Melting Curve Technology
por: Song, Yanhua, et al.
Publicado: (2021)

Correlation of inhA mutations and ethionamide susceptibility: Experience from national reference center for tuberculosis
por: Sarin, Rohit, et al.
Publicado: (2021)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
por: Saito, Renata de Freitas, et al.
Publicado: (2022)

Deep learning-based image-analysis algorithm for classification and quantification of multiple histopathological lesions in rat liver
por: Shimazaki, Taishi, et al.
Publicado: (2021)

Lipid Profile Characterization and Lipoprotein Comparison of Extracellular Vesicles from Human Plasma and Serum
por: Sun, Yuchen, et al.
Publicado: (2019)

Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation
por: Wang, Xu-De, et al.
Publicado: (2011)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Costa-Gouveia, Joana, et al.
Publicado: (2018)

Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
por: Hicks, Nathan D., et al.
Publicado: (2019)

Second-line antitubercular therapy with ethionamide and pyrazinamide causing pellagroid dermatitis presenting as diffuse palmoplantar keratoderma
por: Kura, Mahendra M., et al.
Publicado: (2021)

How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance
por: Maitre, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jv8gjmo4sjm8egek8gr8ai5t8q